Peking University, Mar 16, 2026: An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results